Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor M Montori

Showing results (1-10 of 711) with videos related to

Pageof 72
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2003
Evidence-based endocrine practiceVictor M Montori
BMJ (Clinical Research Ed.)|April 1, 2016
Selecting the right drug treatment for adults with type 2 diabetesVictor M Montori
ACP Journal Club|September 5, 2002
A lifestyle intervention or metformin prevented or delayed the onset of type 2 diabetes in persons at riskVictor M Montori
Circulation. Cardiovascular Quality and Outcomes|March 7, 2017
Big Science: Research Collaboration for Evidence-Based CareVictor M Montori
ACP Journal Club|January 9, 2004
Review: the cosyntropin-stimulation test has limited value for detecting and excluding adrenal insufficiencyVictor M Montori
Academic Medicine : Journal of the Association of American Medical Colleges|May 29, 2019
In Reply to Starr et alVictor M Montori
ACP Journal Club|May 5, 2004
Review: interventions focusing on patient behaviors in provider-patient interactions improve diabetes outcomesVictor M Montori
BMJ (Clinical Research Ed.)|December 10, 2017
Big Science for patient centred careVictor M Montori
Polskie Archiwum Medycyny Wewnetrznej|October 14, 2008
Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk?Victor M Montori
ACP Journal Club|May 4, 2007
Vildagliptin was noninferior to rosiglitazone for glycemic control in type 2 diabetes but caused less weight gainVictor M Montori
Pageof 72

Showing results (1-10 of 711) with videos related to

Sort By:
Pageof 72
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2003
Evidence-based endocrine practiceVictor M Montori
BMJ (Clinical Research Ed.)|April 1, 2016
Selecting the right drug treatment for adults with type 2 diabetesVictor M Montori
ACP Journal Club|September 5, 2002
A lifestyle intervention or metformin prevented or delayed the onset of type 2 diabetes in persons at riskVictor M Montori
Circulation. Cardiovascular Quality and Outcomes|March 7, 2017
Big Science: Research Collaboration for Evidence-Based CareVictor M Montori
ACP Journal Club|January 9, 2004
Review: the cosyntropin-stimulation test has limited value for detecting and excluding adrenal insufficiencyVictor M Montori
Academic Medicine : Journal of the Association of American Medical Colleges|May 29, 2019
In Reply to Starr et alVictor M Montori
ACP Journal Club|May 5, 2004
Review: interventions focusing on patient behaviors in provider-patient interactions improve diabetes outcomesVictor M Montori
BMJ (Clinical Research Ed.)|December 10, 2017
Big Science for patient centred careVictor M Montori
Polskie Archiwum Medycyny Wewnetrznej|October 14, 2008
Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk?Victor M Montori
ACP Journal Club|May 4, 2007
Vildagliptin was noninferior to rosiglitazone for glycemic control in type 2 diabetes but caused less weight gainVictor M Montori
Pageof 72